Invention Grant
- Patent Title: Aryldiazepine derivatives as RSV inhibitors
-
Application No.: US16001247Application Date: 2018-06-06
-
Publication No.: US10752598B2Publication Date: 2020-08-25
- Inventor: Yat Sun Or , Thomas P. Blaisdell , Brian C. Shook , In Jong Kim
- Applicant: Enanta Pharmaceuticals, Inc.
- Applicant Address: US MA Watertown
- Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Elmore Patent Law Group, P.C.
- Agent Carolyn Elmore; Edgar Harlan
- Main IPC: C07D413/14
- IPC: C07D413/14 ; C07D417/14 ; C07D413/12 ; C07D243/14 ; A61K45/06 ; A61P31/14
Abstract:
The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
Public/Granted literature
- US20180354912A1 ARYLDIAZEPINE DERIVATIVES AS RSV INHIBITORS Public/Granted day:2018-12-13
Information query
